UK scientists trial drug to prevent infection that leads to Covid | Coronavirus
British scientists are trialling a new drug that could prevent someone who has been exposed to coronavirus from going ...
Tag: Trial
Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström Syndromes
-- Study met primary endpoint and all key secondary endpoints with statistically significant and clinically meaningful reductions in weight ...
Rhythm Pharmaceuticals (RYTM) Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alstrom Syndromes Met All Endpoints
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here. Study met primary endpoint and all ...
ChemoCentryx and VFMCRP Provide Topline Results from ACCOLADE Trial of Avacopan in C3 Glomerulopathy Including Improved Estimated Glomerular Filtration Rate (eGFR)
As in ANCA vasculitis, avacopan demonstrated statistically significant improvement in renal function as measured by eGFR compared to placebo ...
Korean professor releases trial results of Gilead’s inflammatory bowel disease treatment
Professor Kim Hyo-jong at KyungHee University Hospital made Asia's first presentation of the global phase 3 studies of ulcerative ...
Funding Set for TRM-201 Trial for Joint Disease in Hemophilia
Funding has been set for the RESET-HA Phase 3 clinical trial evaluating Tremeau Pharmaceuticals‘ TRM-201 (rofecoxib) in people with ...
Upstate's Chief of Infectious Diseases, leader of vaccine trial, gets first dose – CNYcentral.com
Upstate's Chief of Infectious Diseases, leader of vaccine trial, gets first dose CNYcentral.com Source link
Mesoblast Provides Topline Results From Phase 3 Trial of Rexlemestrocel-L for Advanced Chronic Heart Failure Australian Stock Exchange:MSB.AX
NEW YORK, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for ...
Free trial yoga class offered virtually | Community
We recognize you are attempting to access this website from a country belonging to the European Economic Area (EEA) ...
Graphite Bio Receives IND Clearance to Initiate Clinical Trial for Next-Generation Gene Editing Therapy GPH101 in Sickle Cell Disease
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Graphite Bio, a next-generation gene editing company focused on therapies that harness targeted DNA integration ...
